Correlation Between Siriuspoint and FibroBiologics, Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Siriuspoint and FibroBiologics, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Siriuspoint and FibroBiologics, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Siriuspoint and FibroBiologics, Common Stock, you can compare the effects of market volatilities on Siriuspoint and FibroBiologics, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Siriuspoint with a short position of FibroBiologics, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Siriuspoint and FibroBiologics, Common.

Diversification Opportunities for Siriuspoint and FibroBiologics, Common

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Siriuspoint and FibroBiologics, is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Siriuspoint and FibroBiologics, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroBiologics, Common and Siriuspoint is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Siriuspoint are associated (or correlated) with FibroBiologics, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroBiologics, Common has no effect on the direction of Siriuspoint i.e., Siriuspoint and FibroBiologics, Common go up and down completely randomly.

Pair Corralation between Siriuspoint and FibroBiologics, Common

Given the investment horizon of 90 days Siriuspoint is expected to generate 0.16 times more return on investment than FibroBiologics, Common. However, Siriuspoint is 6.41 times less risky than FibroBiologics, Common. It trades about 0.1 of its potential returns per unit of risk. FibroBiologics, Common Stock is currently generating about -0.04 per unit of risk. If you would invest  590.00  in Siriuspoint on September 20, 2024 and sell it today you would earn a total of  860.00  from holding Siriuspoint or generate 145.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy45.25%
ValuesDaily Returns

Siriuspoint  vs.  FibroBiologics, Common Stock

 Performance 
       Timeline  
Siriuspoint 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Siriuspoint are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Siriuspoint is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
FibroBiologics, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FibroBiologics, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Siriuspoint and FibroBiologics, Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Siriuspoint and FibroBiologics, Common

The main advantage of trading using opposite Siriuspoint and FibroBiologics, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Siriuspoint position performs unexpectedly, FibroBiologics, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroBiologics, Common will offset losses from the drop in FibroBiologics, Common's long position.
The idea behind Siriuspoint and FibroBiologics, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance